FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer.
Pellegrino M, Rizza P, Donà A, Nigro A, Ricci E, Fiorillo M, Perrotta I, Lanzino M, Giordano C, Bonofiglio D, Bruno R, Sotgia F, Lisanti MP, Sisci D, Morelli C.
Pellegrino M, et al. Among authors: bruno r.
Cancers (Basel). 2019 Nov 25;11(12):1858. doi: 10.3390/cancers11121858.
Cancers (Basel). 2019.
PMID: 31769419
Free PMC article.